LONDON, June 9 (Reuters) – AstraZeneca said on
Thursday it had agreed to sell the commercialisation rights for
its portfolio of anaesthetics outside the United States to South
Africa’s Aspen…
The post AstraZeneca sells rights to anaesthetics to South Africa’s Aspen appeared first on NASDAQ.